Exelixis, Ipsen Say Prostate Cancer Phase 3 Trial Met One of Two Main Goals

By Adria Calatayud Exelixis and Ipsen said a phase 3 clinical trial evaluating a combination of drugs cabozantinib and atezolizumab in metastatic...

Related Keywords

Paris ,France General ,France ,California ,United States ,Adria Calatayud ,Roche Holding ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Genomics ,New Products Services ,Research Development ,Corporate Industrial News ,Products Services ,New Product Service Testing ,Cancer ,Political General News ,Demographic Health ,Health ,Medical Conditions ,Women Amp 39s Health ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Lipsen ,Ipn Fr ,Fr Ipn ,Exelixis ,Rexel ,Us30161q1040 ,Fr0010259150 ,New Products ,Services ,Research ,Development ,Corporate ,Industrial News ,Products ,New Product ,Service Testing ,Political ,General News ,Healthcare ,Life Sciences ,